ω-Agatoxin IVA-sensitive Ca2+ channel blocker, α-eudesmol, protects against brain injury after focal ischemia in rats

European Journal of Pharmacology

Volumn 394, Issue 1, 2000, Pages 57-65

  Asakura, Kenji ^a   Matsuo, Yoshiyuki ^a   Oshima, Takeo ^a   Kihara, Tsuyoshi ^a   Minagawa, Kazuyuki ^a   Araki, Yoshitaka ^a   Kagawa, Kiyomi ^a   Kanemasa, Toshiyuki ^a   Ninomiya, Mitsuyoshi ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Focal ischemia; Glutamate release; Microdialysis; Synaptosome; Eudesmol; Agatoxin IVA sensitive Ca2+ channel

Indexed keywords

ALPHA EUDESMOL; CALCIUM CHANNEL; GLUTAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN SYNAPTOSOME; CONTROLLED STUDY; MALE; MICRODIALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN EDEMA; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; CEREBRAL INFARCTION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; MALE; NEUROPROTECTIVE AGENTS; OMEGA-AGATOXIN IVA; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SESQUITERPENES, EUDESMANE; TERPENES;

EID: 0034615882     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00102-3     Document Type: Article

References (50)

1. 2+ uptake. Brain Res. 823:1999;169-176.
2. 2+ channel blocker ω-agatoxin IVA protects against brain injury after focal ischemia in rats. Brain Res. 776:1997;140-145.
3. Attwell D., Barbour B., Szatkowski M. Non-vesicular release of neurotransmitter. Neuron. 11:1993;401-407.
4. Benveniste H., Drejer J., Diemer H.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
5. 2+ channel blocker prevents CA1 injury 24 h following focal ischemia. J. Cereb. Blood Flow Metab. 14:1994;903-910.
6. Busto R., Dietrich W.D., Globus M.Y.-Y., Valdes I., Scheinberg P., Ginsberg M.D. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7:1987;729-738.
7. Butcher S.P., Bullock R., Graham D.I., Mcculloch J. Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke. 21:1990;1727-1733.
8. Chen H., Chopp M., Zhang Z.G., Garcia J.H. The effect of hypothermia on transient middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 12:1992;621-628.
9. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
10. Diaz A., Dickenson A.H. Blockade of spinal N- and P-type, but not L-type, calcium channels inhibits the excitability of rat dorsal horn neurons produced by subcutaneous formalin inflammation. Pain. 69:1997;93-100.
11. 2+ channels in mammalian central neurons. Trends Neurosci. 18:1995;89-98.
12. Gemba T., Oshima T., Ninomiya M. Glutamate efflux via the reversal of the sodium-dependent glutamate transporter caused by glycolytic inhibition in rat cultured astrocytes. Neuroscience. 63:1994;789-795.
13. Graham M.J., Burgoyne R.D. Effects of calcium channel antagonists on calcium entry and glutamate release from cultured rat cerebellar granule cells. J. Neurochem. 65:1995;2517-2524.
14. Grantham C.J., Main M.J., Cannell M.B. Fluspirilene block of N-type calcium current in NGF-differentiated PC12 cells. Br. J. Pharmacol. 111:1994;483-488.
15. Hillered L., Hallstrom A., Segersaard S., Persson L., Ungerstedt U. Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. J. Cereb. Blood Flow Metab. 9:1989;607-616.
16. 2+ channels mediate excitatory and inhibitory synaptic transmitter release in crayfish muscle. Proc. Natl. Acad. Sci., U.S.A. 91:1994;4224-4228.
17. 2+ channels by two mechanisms. Brain Res. 702:1995;207-212.
18. Katayama Y., Kawamata T., Tamura T., Hovda D.A., Becker D.P., Tsubokawa T. Calcium-dependent glutamate release concomitant with massive potassium flux during cerebral ischemia in vivo. Brain Res. 558:1991;136-140.
19. 2+ channels as drug targets for the treatment of epilepsy or ischemic stroke. Neuropharmacology. 36:1997;107-113.
20. 2+ channels in the mammalian central nervous system. Trends Neurosci. 15:1992;351-355.
21. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke. 20:1989;84-91.
22. Lu Y.M., Frostl W., Dreessen J., Knopfel T. P-type calcium channels are blocked by the alkaloid daurisoline. NeuroReport. 5:1994;1489-1492.
23. Luebke J.I., Dunlap K., Turner T.J. Multiple calcium channel types control glutamatergic synaptic transmission in the hippocampus. Neuron. 11:1993;895-902.
24. Matsuo Y., Onodera H., Shiga Y., Nakamura M., Ninomiya M., Kihara T., Kogure K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat: effects of neutrophil depletion. Stroke. 25:1994;1469-1475.
25. 2+ channels present in synaptosomes from rat and chicken central nervous system. J. Neurochem. 64:1995;2544-2551.
26. Mintz I.M., Adams M.E., Bean B.P. P-type calcium channels in rat central and peripheral neurons. Neuron. 9:1992;85-89.
27. Mintz I.M., Venema V.J., Swiderek K.M., Lee T.D., Bean B.P., Adams M.E. P-type calcium channels blocked by the spider toxin ω-Aga-IVA. Nature. 355:1992;827-829.
28. Momiyama A., Takahashi T. Calcium channels responsible for potassium-induced transmitter release at rat cerebellar synapse. J. Physiol. (London). 476:1994;197-202.
29. Morikawa E., Ginsenberg M.D., Dietrich W.D., Duncan R.C., Kraydieh S., Globus M.Y.-T., Busto R. The significance of brain temperature in focal cerebral ischemia: histopathological consequences of mild cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 12:1992;380-389.
30. Mulkey P.M., Zucker R.S. Action potential must admit calcium to evoke transmitter release. Nature. 350:1991;153-155.
31. Nebe J., Vanegas H., Neugebauer V., Schaible H.G. Omega-agatoxin IVA, a P-type calcium channel antagonist, reduces nociceptive processing in spinal cord neurons with input from the inflamed but not from the normal knee joint: an electrophysiological study in the rat in vivo. Eur. J. Neurosci. 9:1997;2193-2201.
32. Norris T.M., Moya E., Blagbrough I.S., Adams M.E. Block of high-threshold calcium channels by the synthetic polyamines sFTX-3.3 and FTX-3.3. Mol. Pharmacol. 50:1996;939-946.
33. 2+ channel currents in rat cerebellar granule neurons. J. Neurosci. 15:1995;2995-3012.
34. Ravindran J., Shuaib A., Ijaz S., Galazka P., Waqar T., Ishaqzy R., Miyashita H., Liu L. High extracellular GABA levels in hippocampus-as a mechanism of neuronal protection in cerebral ischemia in adrenalectomized gerbils. Neurosci. Lett. 176:1994;209-211.
35. Regehr W.G., Mintz I.M. Participation of multiple calcium channel types in transmission at single climbing fiber to Purkinje cell synapses. Neuron. 12:1994;605-613.
36. Sah D.W.Y., Bean B.P. Inhibition of P-type and N-type calcium channels by dopamine receptor antagonists. Mol. Pharmacol. 45:1993;84-92.
37. Simon R.P., Swan J.H., Griffiths T., Meldrum B.S. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 226:1984;850-852.
38. Small D.L., Monette R., Mealing G., Buchan A.M., Morley P. Neuroprotective effects of ω-Aga-IVA against in vitro ischaemia in the rat hippocampal slice. NeuroReport. 6:1995;1617-1620.
39. Syunya T., Matsushima K., Fujita H., Nanri K., Ogawa S., Shinohara Y. A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 15:1995;611-618.
40. Thomas M.M., Puligandla P.S., Dunn S.M.J. Effects of calcium channel blockers on the kinetics of voltage-dependent changes in synaptosomal calcium concentrations. Brain. Res. 635:1994;9-17.
41. Turner T., Adams M.E., Dunlap K. Calcium channels coupled to glutamate release identified by ω-Aga-IVA. Science. 258:1992;310-313.
42. Turner T., Dunlap K. Pharmacological characterization of presynaptic calcium channels using subsecond biochemical measurements of synaptosomal neurosecretion. Neuropharmacology. 34:1995;1469-1478.
43. Uchitel O.D., Protti D.A., Sanchez V., Cherksey B.D., Sugimori M., Llinas R. P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc. Natl. Acad. Sci., U.S.A. 89:1992;3330-3333.
44. Usowicz M.M., Sugimori M., Cherksey B., Llinas R. P-type calcium channels in the somata and dendrites of adult cerebellar Purkinje cells. Neuron. 9:1992;1185-1199.
45. 2+ channels in supporting hippocampal synaptic transmission. Science. 264:1994;107-111.
46. Wu G., Kim H.K., Zornow M.H. Transient brain ischemia in rabbits: the effect of ω-conopeptide MVIIC hippocampal excitatory amino acids. Brain Res. 692:1995;118-122.
47. Yamada K., Teraoka T., Hasegawa T., Nabeshima T. ω-Conotoxin GVIA protects against ischemia-induced neuronal death in the Mongolian gerbil but not against quinolinic acid-induced neurotoxicity in the rat. Neuropharmacology. 33:1994;251-254.
48. Yenari M.A., Palmer J., Sun G.H., de Crespigny A., Moseley M.E., Steinberg G.K. Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI. Brain Res. 739:1996;36-45.
49. 2+ channels and their possible counterparts in mammalian CNS neuron. Neuropharmacology. 32:1993;1075-1088.
50. Zhao Q., Smith M.-L., Siesjö B.K. The ω-conopeptide, SNX-111, an N-type calcium channel blocker, dramatically ameliorates brain damage due to transient focal ischemia. Acta Physiol. Scand. 150:1994;459-461.